top border colored line

Watch Leading Oncology Specialists Discuss The Current Lung Cancer Landscape

Coming Soon

Epidemiology, Screening, and Staging of Lung Cancer

Treatment of Resectable and Unresectable Stage III NSCLC and LS-SCLC

Treatment of Metastatic NSCLC and ES-SCLC

Expert Panel

J. Jay Zhang, MD, PhD

J. Jay Zhang, MD, PhD

Associate Professor
UT MD Anderson Cancer Center
Houston, Texas

Carl Gay, MD, PhD

Carl Gay, MD, PhD

Assistant Professor
UT MD Anderson Cancer Center
Houston, Texas

Xiuning Le, MD, PhD

Xiuning Le, MD, PhD

Assistant Professor
UT MD Anderson Cancer Center
Houston, Texas

Program Objectives

Discuss biomarker testing and treatment options for metastatic NSCLC

Review considerations in the management of ES-SCLC

Explore ways to help manage treatment-related adverse events in patients with lung cancer

Exelixis Logo